Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GAD65”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Study completedNCT02464033
What this trial is testing

EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 20
Testing effectiveness (Phase 2)Study completedNCT00435981
What this trial is testing

Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Diamyd Therapeutics AB 70
Not applicableLooking for participantsNCT07133113
What this trial is testing

Medium-term Effects of Treatments in Autoimmune Encephalitis

Who this might be right for
NMDAR Autoimmune EncephalitisLGI1 Antibody Associated EncephalitisCASPR2-Antibody+3 more
Hospices Civils de Lyon 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05018585
What this trial is testing

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Medical AB 321
Not applicableLooking for participantsNCT05017142
What this trial is testing

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Who this might be right for
Optic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more
University of Bern 500
Testing effectiveness (Phase 2)Study completedNCT01785108
What this trial is testing

DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 60
Early research (Phase 1)Study completedNCT02352974
What this trial is testing

GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 12
Testing effectiveness (Phase 2)Study completedNCT05351879
What this trial is testing

Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Linkoeping University 6
Testing effectiveness (Phase 2)Study completedNCT03345004
What this trial is testing

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes MellitusAutoimmune Diseases+9 more
Diamyd Medical AB 109
Testing effectiveness (Phase 2)Ended earlyNCT00837759
What this trial is testing

Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus Type 1Autoimmune Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05683990
What this trial is testing

Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Autoimmune DiseasesPrevention
Diamyd Medical AB 5
Testing effectiveness (Phase 2)WithdrawnNCT05361447
What this trial is testing

Diazepam Trial in GAD65 Associated Epilepsy

Who this might be right for
GAD 65 Antibody-associated Epilepsy
Mayo Clinic